Procurement and implantation of L11 and L03 telemetry devices into non-human primates.

Ended Awarded Last action

Contract number
HT942524F0317
Awardee
Awarding agency
Obligated
$235,557

Award facts

Contract value 100% obligated
$235,556.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
339113 Surgical Appliance and Supplies Manufacturing
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
ABER PROV GRD, MD 21010, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a $235,556.60 firm fixed-price call order to Harvard Bioscience Inc. (operating as Data Sciences International) for the procurement and implantation of L11 and L03 telemetry devices into non-human primates. This award, effective December 31, 2024 with completion targeted for March 27, 2025, will be performed at Aberdeen Proving Ground, Maryland. The contract represents a task order issued under Harvard Bioscience's existing $4.8 million single-award Blanket Purchase Agreement with the Defense Health Agency, which was established in May 2022 and runs through May 3, 2027. No set-aside designation was applied to this procurement.

Harvard Bioscience, a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, specializes in advanced physiological monitoring technologies and wireless implantable telemetry systems. The company has extensive experience delivering sophisticated biomedical research equipment to multiple federal agencies including the Department of Defense, National Institutes of Health, Department of Veterans Affairs, and Environmental Protection Agency. Under the Defense Health Agency BPA, the company provides comprehensive solutions including telemetry devices, pre-implanted research animals, surgical implantation services, and data acquisition systems that support critical defense and military health sector research initiatives. This call order continues Harvard Bioscience's established role as a primary supplier of specialized telemetry solutions for preclinical research programs.

Quick answers

Who was awarded contract HT942524F0317?

HT942524F0317 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on December 31, 2024.

How much is contract HT942524F0317 worth?

The government has obligated $235,557 on HT942524F0317.

Is contract HT942524F0317 an order under another contract?

Yes. HT942524F0317 is a BPA call under W81XWH22A0001, a blanket purchase agreement.

Was contract HT942524F0317 competed?

The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award